Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia

Autor: Myrthe E. Sonneveld, Susanna Sainio, J. M. Koelewijn, C. Ellen van der Schoot, Jukka Partanen, Manfred Wuhrer, Suvi Natunen, Gestur Vidarsson, Carolien A. M. Koeleman, Stephanie Holst, Gillian Dekkers
Přispěvatelé: Other departments, Landsteiner Laboratory, Clinical Haematology
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Zdroj: British journal of haematology, 174(2), 310-320. Wiley-Blackwell
British Journal of Haematology, 174(2), 310-320. WILEY-BLACKWELL
ISSN: 0007-1048
Popis: Fetal or neonatal alloimmune thrombocytopenia (FNAIT) is a potentially life-threatening disease where fetal platelets are destroyed by maternal antiplatelet IgG alloantibodies. The clinical outcome varies from asymptomatic, to petechiae or intracranial haemorrhage, but no marker has shown reliable correlation with severity, making screening for FNAIT impractical and highly inefficient. We recently found IgG Fc-glycosylation towards platelet and red blood cell antigens to be skewed towards decreased fucosylation, increased galactosylation and sialylation. The lowered core-fucosylation increases the affinity of the pathogenic antibodies to Fc gamma RIIIa and Fc gamma RIIIb, and hence platelet destruction. Here we analysed the N-linked glycans of human platelet antigen (HPA)-1a specific IgG1 with mass spectrometry in large series of FNAIT cases (n = 166) including longitudinal samples (n = 26). Besides a significant decrease in Fc-fucosylation after the first pregnancy (P = 0.0124), Fc-glycosylation levels remained stable during and after pregnancy and in subsequent pregnancies. Multiple logistic regression analysis identified anti-HPA-1a - fucosylation (P = 0.006) combined with galactosylation (P = 0.021) and antibody level (P = 0.038) correlated with bleeding severity, making these parameters a feasible marker in screening for severe cases of FNAIT.
Databáze: OpenAIRE